Appendix 4E and 2016 Annual Report

$ Dividends There were no dividends paid, recommended or declared during the current financial period. Comments The loss for the Group after providing for income tax amounted to $1,080,784 (30 June 2015: $8,470,382). 3. Net tangible assets Cents Cents Net tangible assets per ordinary security 0.39 0.57 4. Control gained over entities Name of entities (or group of entities) Nucleus Therapeutics Pty